Dual amplification for PEC ultrasensitive aptasensing of biomarker HER-2 based on Z-scheme UiO-66/CdIn 2 S 4 heterojunction and flower-like PtPdCu nanozyme.

Autor: Ai QY; Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, College of Geography and Environmental Sciences, Zhejiang Normal University, Jinhua, 321004, China., Xu BF; Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, College of Geography and Environmental Sciences, Zhejiang Normal University, Jinhua, 321004, China., Xu F; Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, College of Geography and Environmental Sciences, Zhejiang Normal University, Jinhua, 321004, China., Wang AJ; Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, College of Geography and Environmental Sciences, Zhejiang Normal University, Jinhua, 321004, China., Mei LP; Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, College of Geography and Environmental Sciences, Zhejiang Normal University, Jinhua, 321004, China., Wu L; Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, College of Geography and Environmental Sciences, Zhejiang Normal University, Jinhua, 321004, China. Electronic address: krwl@zjnu.cn., Song P; Central Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, China. Electronic address: peisong@zju.edu.cn., Feng JJ; Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, College of Geography and Environmental Sciences, Zhejiang Normal University, Jinhua, 321004, China. Electronic address: jjfeng@zjnu.cn.

Publikováno v: Talanta [Talanta] 2024 Jul 01; Vol. 274, pp. 126034. Date of Electronic Publication: 2024 Apr 03.

Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions.

Autor: Lam WKJ; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Centre for Novostics, Hong Kong Science Park, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., King AD; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Miller JA; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Liu Z; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Yu KJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Chua MLK; Department of Head and Neck and Thoracic Cancers, Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore., Ma BBY; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Chen MY; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Center for Precision Medicine of Sun Yat-sen University, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China., Pinsky BA; Department of Pathology, Stanford University, Stanford, CA, USA., Lou PJ; Department of Otolaryngology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan., Woo JKS; Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Hsu WL; Master Program of Big Data in Biomedicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.; Data Science Center, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan., Simon J; Infections and Cancer Epidemiology, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany., Doolan DL; Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Australia., Waterboer T; Infections and Cancer Epidemiology, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hui EP; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Li H; Department of Radiology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China., Tsang RK; Department of Otolaryngology-Head and Neck Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Wong KCW; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Goh JP; Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore, Singapore., Vlantis AC; Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Ai QY; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China., Wong LM; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Abdullah V; Department of Otorhinolaryngology, Hong Kong Children's Hospital, Hong Kong SAR, China.; The Hong Kong College of Otorhinolaryngologists, Hong Kong SAR, China., Lin JC; Department of Radiation Oncology, Changhua Christian Hospital, Changhua, Taiwan., Chen CJ; Genomics Research Center, Academia Sinica, Taipei, Taiwan., Pfeiffer RM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Le QT; Department of Radiation Oncology, Stanford University, Stanford, CA, USA., Lee AWM; Clinical Oncology Center, Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, The University of Hong Kong-Shenzhen Hospital, Guangdong, China.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong SAR, China., Ji M; Cancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, China., Cao S; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Center for Precision Medicine of Sun Yat-sen University, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; Department of Cancer Prevention, Sun Yat-sen University Cancer Center, Guangzhou, China., Ma J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Center for Precision Medicine of Sun Yat-sen University, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China., Chan ATC; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Chan KCA; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; Centre for Novostics, Hong Kong Science Park, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Hildesheim A; Agencia Costarricense de Investigaciones Biológicas (ACIB) - Fundacion del Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (INCIENSA), San José, Costa Rica.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Apr 11; Vol. 115 (4), pp. 355-364.

Targeting the polycomb repressive complex-2 related proteins with novel combinational strategies for nasopharyngeal carcinoma.

Autor: Zhu J; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong, China., Li L; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong, China., Tong J; Department of Anatomical and Cellular Pathology, The Prince of Wales Hospital Hong Kong, China., Hui C; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong, China., Wong CH; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong, China., Lo KW; Department of Anatomical and Cellular Pathology, The Prince of Wales Hospital Hong Kong, China., Chan R; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong, China., Ai QY; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong Hong Kong, China., Hui EP; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong, China., Chan AT; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong, China., To KF; Department of Anatomical and Cellular Pathology, The Prince of Wales Hospital Hong Kong, China., Tao Q; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong, China., Ma BB; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital Hong Kong, China.

Publikováno v: American journal of cancer research [Am J Cancer Res] 2020 Oct 01; Vol. 10 (10), pp. 3267-3284. Date of Electronic Publication: 2020 Oct 01 (Print Publication: 2020).

Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma.

Autor: King AD; From the Departments of Imaging and Interventional Radiology (A.D.K., Q.Y.A., T.Y.S., K.W.N.Y.) king2015@cuhk.edu.hk., Woo JKS; Otorhinolaryngology, Head and Neck Surgery (J.K.S.W., A.C.V.)., Ai QY; Clinical Oncology (F.K.F.M., E.P.H., B.B.Y.M., A.T.C.C.)., Mo FKF; Chemical Pathology (W.K.J.L., I.O.L.T., R.W.K.C., Y.M.D.L., K.C.A.C.).; Li Ka Shing Institute of Health Sciences (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., So TY; From the Departments of Imaging and Interventional Radiology (A.D.K., Q.Y.A., T.Y.S., K.W.N.Y.)., Lam WKJ; Chemical Pathology (W.K.J.L., I.O.L.T., R.W.K.C., Y.M.D.L., K.C.A.C.).; Li Ka Shing Institute of Health Sciences (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Hong Kong SAR, China., Tse IOL; Chemical Pathology (W.K.J.L., I.O.L.T., R.W.K.C., Y.M.D.L., K.C.A.C.).; Li Ka Shing Institute of Health Sciences (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Hong Kong SAR, China., Vlantis AC; Otorhinolaryngology, Head and Neck Surgery (J.K.S.W., A.C.V.)., Yip KWN; From the Departments of Imaging and Interventional Radiology (A.D.K., Q.Y.A., T.Y.S., K.W.N.Y.)., Hui EP; Clinical Oncology (F.K.F.M., E.P.H., B.B.Y.M., A.T.C.C.).; Chemical Pathology (W.K.J.L., I.O.L.T., R.W.K.C., Y.M.D.L., K.C.A.C.).; Li Ka Shing Institute of Health Sciences (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Ma BBY; Clinical Oncology (F.K.F.M., E.P.H., B.B.Y.M., A.T.C.C.).; Chemical Pathology (W.K.J.L., I.O.L.T., R.W.K.C., Y.M.D.L., K.C.A.C.).; Li Ka Shing Institute of Health Sciences (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Chiu RWK; Chemical Pathology (W.K.J.L., I.O.L.T., R.W.K.C., Y.M.D.L., K.C.A.C.).; Li Ka Shing Institute of Health Sciences (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Hong Kong SAR, China., Chan ATC; Clinical Oncology (F.K.F.M., E.P.H., B.B.Y.M., A.T.C.C.).; Chemical Pathology (W.K.J.L., I.O.L.T., R.W.K.C., Y.M.D.L., K.C.A.C.).; Li Ka Shing Institute of Health Sciences (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Lo YMD; Chemical Pathology (W.K.J.L., I.O.L.T., R.W.K.C., Y.M.D.L., K.C.A.C.).; Li Ka Shing Institute of Health Sciences (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Hong Kong SAR, China., Chan KCA; Chemical Pathology (W.K.J.L., I.O.L.T., R.W.K.C., Y.M.D.L., K.C.A.C.).; Li Ka Shing Institute of Health Sciences (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China.; State Key Laboratory of Translational Oncology (F.K.F.M., W.K.J.L., I.O.L.T., E.P.H., B.B.Y.M., R.W.K.C., A.T.C.C., Y.M.D.L., K.C.A.C.), The Chinese University of Hong Kong, Hong Kong SAR, China.

Publikováno v: AJNR. American journal of neuroradiology [AJNR Am J Neuroradiol] 2020 Mar; Vol. 41 (3), pp. 515-521.

Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma.

Autor: King AD; Departments of Imaging and Interventional Radiology. Electronic address: king2015@cuhk.edu.hk., Woo JKS; Otorhinolaryngology, Head and Neck Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR., Ai QY; Departments of Imaging and Interventional Radiology., Chan JSM; Departments of Imaging and Interventional Radiology., Lam WKJ; Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR; Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China., Tse IOL; Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR; Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China., Bhatia KS; Department of Imaging, St Mary's Hospital, Imperial College Healthcare, National Health Service Trust, London, UK., Zee BCY; Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR., Hui EP; Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Ma BBY; Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Chiu RWK; Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR; Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China., van Hasselt AC; Otorhinolaryngology, Head and Neck Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR., Chan ATC; Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China., Lo YMD; Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR; Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China., Chan KCA; Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR; Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Jun 01; Vol. 30 (6), pp. 977-982.